Long-acting injections are a type of preparation that can be administered through the injection route and slowly release drugs in the body, thereby prolonging the duration of drug action. This type of injection has been widely used in the treatment of various diseases due to its prolonged drug action time, reduced dosing frequency, and improved patient compliance.
Overview of Market Development
Market size and growth: The long-acting injection market continues to grow due to the expansion of the patient population. According to our research data, the estimated global long-acting injection market size in 2024 is $18.70 billion, an increase of 11.02% compared to 2023, and is expected to continue growing to $29.96 billion by 2029. The CAGR for 2024-2029 is estimated to be 9.89%.
Market driving factors: accelerated aging process, increased burden of chronic diseases, and advances in biotechnology and pharmaceutical technology are the main factors driving the development of the long-acting injection market.
Analysis of Downstream Application Pattern
From downstream applications, long-acting injections are mainly used in schizophrenia treatment and bipolar disorder treatment. Among them, the field of schizophrenia treatment holds the highest market share in downstream applications, estimated to be 51.20% in 2024.
Global Long-Acting Injection Market Size and Market Share by Type Forecast
Source: www.globalmarketmonitor.com
Market Analysis of Major Regions
From a regional perspective, the global long-acting injection market is dominated by three major regions: North America, Europe, and Asia Pacific. The total revenue of the long-acting injection market in these three regions accounts for approximately 95% of the global total revenue. Among them, North America is the largest revenue market. Data shows that the revenue of the North American long-acting injection market is expected to reach $9920 million in 2024, with an estimated revenue share of 53.06%.
Global Long-Acting Injectable Market Revenue and Revenue Share by Region Forecast in 2024
|
Regions
|
Market Revenue (Million USD)
|
Revenue Share
|
|
North America
|
9920
|
53.06%
|
|
Europe
|
4425
|
23.67%
|
|
Asia Pacific
|
3252
|
17.40%
|
|
South America
|
572
|
3.06%
|
|
Middle East & Africa
|
527
|
2.82%
|
Source: www.globalmarketmonitor.com
For more industry information, please refer to our latest released "2023 Global Long-Acting Injectables Market Analysis Report, Key Competitors, Market Effect Factors, Growth, And Forecast".
Chinese